Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

kConFab, Lim, Elgene, Vaillant, François, Wu, Di, Forrest, Natasha C, Pal, Bhupinder, Hart, Adam H, Asselin-Labat, Marie-Liesse +13 more·2009·Nature Medicine

Cited by (1,001)

Items 601–700 of 1,001

  1. Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Lovisa Odén, Mohammad Reza Akbari, Tasnim Zaman, Christian Fridolin Singer, Ping Sun, Steven Alexander Narod, Leonardo Salmena, Joanne Kotsopoulos · 2016 · Oncotarget
  2. Basal-like Breast Cancers: From Pathology to Biology and Back Again
    Barry A. Gusterson, Connie J. Eaves · 2018 · Stem Cell Reports
  3. Small Players With Big Roles: MicroRNAs as Targets to Inhibit Breast Cancer Progression
    Stephanie B. Greene, Jason I. Herschkowitz, Jeffrey M. Rosen · 2010 · Current Drug Targets
  4. Aging is associated with an expansion of CD49fhi mammary stem cells that show a decline in function and increased transformation potential
    Dong, Qiaoxiang, Gao, Hui, Shi, Yuanshuo, Zhang, Fuchuang, Gu, Xiang, Wu, Anqi, Wang, Danhan, Chen, Yuanhong, Bandyopadhyay, Abhik, Yeh, I-Tien et al. · 2016 · Aging
  5. Models of Breast Morphogenesis Based on Localization of Stem Cells in the Developing Mammary Lobule
    Gabriella Honeth, Tommaso Schiavinotto, Federico Vaggi, Rebecca Marlow, Tokuwa Kanno, Ireneusz Shinomiya, Sara Lombardi, Bharath Buchupalli, Rosalind A. Graham, Patrycja Gazińska et al. · 2015 · Stem Cell Reports
  6. Epigenetic inactivation of DNA repair in breast cancer
    Somaira Nowsheen, Khaled Aziz, Phuoc Tho Tran, Vassilis G. Gorgoulis, Eddy Shih-Hsin Yang, Alexandros G. Georgakilas · 2012 · Cancer Letters
  7. The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis
    Chris Hemmings · 2010 · Pathology
  8. Triggering a switch from basal- to luminal-like breast cancer subtype by the small-molecule diptoindonesin G via induction of GABARAPL1
    Minmin Fan, Jingwei Chen, Jian Gao, Wenwen Xue, Yixuan Wang, Wuhao Li, Lin Zhou, Xin Li, Chengfei Jiang, Yang Sun et al. · 2020 · Cell Death and Disease
  9. The molecular consequences of androgen activity in the human breast
    Florian Raths, Mehran Karimzadeh, Nathan Ing, Andrew Martinez, Yoona Yang, Ying Qu, Tian-Yu Lee, Brianna Mulligan, Suzanne Devkota, Wayne T. Tilley et al. · 2023 · Cell Genomics
  10. Quantitation of human mammary epithelial stem cells with in vivo regenerative properties using a subrenal capsule xenotransplantation assay
    Peter D. Eirew, Julia Stingl, Connie J. Eaves · 2010 · Nature Protocols
  11. Good cells gone bad: the cellular origins of cancer.
    Jean C. Y. Wang · 2010 · Trends in Molecular Medicine
  12. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits
    Bhupinder Pal, Yunshun Chen, Andrew G. Bert, Yifang Hu, Julie M. Sheridan, Tamara J Beck, Wei Shi, Keith Satterley, Paul R. Jamieson, Gregory J. Goodall et al. · 2015 · Breast Cancer Research
  13. Targeting breast cancer initiating cells: Advances in breast cancer research and therapy
    James Andrew McCubrey, Nicole M. Davis, Stephen Lee Abrams, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Ferdinando Nicoletti, Antonino B. D’Assoro, Lucio Cocco, Alberto Maria Martelli et al. · 2014 · Advances in Biological Regulation
  14. Minimizing the risk of cancer: tissue architecture and cellular replication limits
    Ignacio A. Rodriguez-Brenes, D. Wodarz, N. Komarova · 2013 · Journal of the Royal Society Interface
  15. Improved efficacy of mitochondrial disrupting agents upon inhibition of autophagy in a mouse model of BRCA1-deficient breast cancer
    Syn Kok Yeo, Ritama Paul, Michael Haas, Chenran Wang, Jun‐Lin Guan · 2018 · Autophagy
  16. LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state
    Noa Furth, Ioannis S. Pateras, Ron Rotkopf, Vassiliki Vlachou, Irina Rivkin, Ina Schmitt, Deborah Bakaev, Anat Gershoni, Elena Ainbinder, Dena Leshkowitz et al. · 2018 · Life Science Alliance
  17. Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traits
    Gadisti Aisha Mohamed, Sundis Mahmood, Nevena B. Ognjenovic, Min Kyung Lee, Owen Michael Wilkins, Brock C. Christensen, Kristen E. Muller, Diwakar Ram Pattabiraman · 2023 · Breast Cancer Research
  18. Regulation of human Cripto‐1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells
    Caterina Bianco, Nadia Pereira de Castro, Christina Baraty, Kelly Rollman, Natalie Held, María Cristina Rangel, Hideaki Karasawa, Monica Gonzales, Luigi Strizzi, David S. Salomon · 2012 · Journal of Cellular Physiology
  19. Phenotype-Genotype Correlation in Familial Breast Cancer
    Ana Cristina Vargas, Jorge Sergio Reis-Filho, Sunil R. Lakhani · 2011 · Journal of Mammary Gland Biology and Neoplasia
  20. Writing and Rewriting the Epigenetic Code of Cancer Cells: From Engineered Proteins to Small Molecules
    Pilar Blancafort, Jian Jun Jin, Stephen V. Frye · 2012 · Molecular Pharmacology
  21. AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer
    Agnete S. T. Engelsen, Katarzyna Wnuk-Lipińska, Sébastien Bougnaud, Fanny A. Pelissier Vatter, Crina Elena Tiron, René Villadsen, Masaru Miyano, Maria Lie Lotsberg, Noëlly Madeleine, Pouda Panahandeh et al. · 2020 · iScience
  22. Network Analysis Identifies Regulators of Basal-Like Breast Cancer Reprogramming and Endocrine Therapy Vulnerability
    Sea Rom Choi, Chae Young Hwang, Jonghoon Lee, Kwang‐Hyun Cho · 2021 · Cancer Research
  23. Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
    Mai Rachel Nguyen, Clodia Osipo · 2022 · International Journal of Molecular Sciences
  24. Bisphenol A Induces Sox2 in ER+ Breast Cancer Stem-Like Cells
    M. Angeles Lillo, Cydney M. Nichols, Tiffany Nicole Seagroves, Gustavo A. Miranda‐Carboni, Susan A. Krum · 2017 · Hormones and Cancer
  25. Age‐related phenotypes in breast cancer: A population‐based study
    Amalie A. Svanøe, Rasmus O. C. Humlevik, Gøril Knutsvik, Anna Kristine Myrmel Sæle, Cecilie Askeland, Lise Martine Ingebriktsen, Ulrikke Hugaas, Amalie B. Kvamme, Amalie F. Tegnander, Kristi Krüger et al. · 2024 · International Journal of Cancer
  26. Fibroblasts direct differentiation of human breast epithelial progenitors
    Mikkel Morsing, Jiyoung Kim, René Villadsen, Nadine Goldhammer, Abbas Jafari, Moustapha S Kassem, OLE WILLIAM PETERSEN, Lone Rønnov‐Jessen · 2020 · Breast Cancer Research
  27. Mammary gland development from a single cell ‘omics view
    Alecia‐Jane Twigger, Walid T. Khaled · 2021 · Seminars in Cell and Developmental Biology
  28. Microenvironmental control of cell fate decisions in mammary gland development and cancer
    Gat Rauner, Charlotte Kuperwasser · 2021 · Developmental Cell
  29. Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
    Joseph G. Kern, Andrew Tilston-Lünel, Anthony N. Federico, Boting Ning, Amy Mueller, Grace B. Peppler, Eleni Stampouloglou, Nan Cheng, Randy L. Johnson, Marc E. Lenburg et al. · 2022 · Nature Communications
  30. Immunophenotypic predictive profiling of BRCA1-associated breast cancer
    Paweł Domagała, Tomasz Huzarski, Jan Lubiński, Karol Gugała, W Domagała · 2010 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  31. Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells
    Werner Boecker, Göran Stenman, Thomas Loening, Mattias K. Andersson, Tobias Berg, Alina Lange, Ágnes Bánkfalvi, Vera E. Samoilova, Katharina Tiemann, Igor Buchwalow · 2014 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  32. Mechanisms that clear mutations drive field cancerization in mammary tissue
    Marta Ciwinska, Hendrik A. Messal, Hristina R Hristova, Catrin Lutz, Laura Bornes, Theofilos Chalkiadakis, Rolf Harkes, Nathalia S. M. Langedijk, Stefan J. Hutten, Renée X. de Menezes et al. · 2024 · Nature
  33. Mechanism of action of genistein on breast cancer and differential effects of different age stages
    Zhebin Xiang, Bo Ma, Xiujun Pei, Wenjie Wang, Weilun Gong · 2025 · Pharmaceutical Biology
  34. BRCA1 – Conductor of the Breast Stem Cell Orchestra: The Role of BRCA1 in Mammary Gland Development and Identification of Cell of Origin of BRCA1 Mutant Breast Cancer
    Niamh E. Buckley, Paul B. Mullan · 2012 · Stem Cell Reviews and Reports
  35. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes
    Yongsheng Li, Shengli Li, Juan Chen, Tingting Shao, Chunjie Jiang, Yuan Wang, Hong Chen, Juan Xu, Xia Li · 2014 · Human Molecular Genetics
  36. Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based “starvation” strategies in BRCA1 carriers
    Elisabet Cuyàs, Salvador Fernández‐Arroyo, Tomás Alarcón, Ruth Lupu, Jorge Joven, Javier Abel Menéndez · 2016 · Oncotarget
  37. Molecular mechanism of triple‑negative breast cancer‑associated BRCA1 and the identification of signaling pathways
    Qi, Feng, Qin, Wen‑Xing, Zang, Yuan‑Sheng · 2019 · Oncology Letters
  38. Hybrid Stem Cell States: Insights Into the Relationship Between Mammary Development and Breast Cancer Using Single-Cell Transcriptomics
    Tasha Thong, Yutong Wang, Michael D. Brooks, Christopher Tai-Yi Lee, Clayton D. Scott, Laura Balzano, Max S. Wicha, Justin A. Colacino · 2020 · Frontiers in Cell and Developmental Biology
  39. Elemental bioimaging shows mercury and other toxic metals in normal breast tissue and in breast cancers
    Roger Pamphlett, Laveniya Satgunaseelan, Stephen Kum Jew, Philip Doble, David Bishop · 2020 · PLoS ONE
  40. Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
    Kotsopoulos, Joanne, Singer, Christian, Narod, Steven A. · 2017 · Breast Cancer Research and Treatment
  41. Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
    Marise R. Heerma van Voss, Petra van der Groep, Joost Bart, Elsken van der Wall, P. J. van Diest · 2011 · Cellular Oncology
  42. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53 deficient mammary cancers
    Adam D. Pfefferle, Yash Agrawal, Daniel C. Koboldt, Krishna Kanchi, Jason I. Herschkowitz, Elaine R. Mardis, Jeffrey M. Rosen, Charles M. Perou · 2016 · Disease Models & Mechanisms
  43. Isoproterenol regulates CD44 expression in gastric cancer cells through STAT3/MicroRNA373 cascade
    Bo Wei, Xiaoyan Sun, Zhijun Geng, Ming Shi, Zhida Chen, Lin Chen, Yongan Wang, Xiaobing Fu · 2016 · Biomaterials
  44. Cytokeratin 5 alters β-catenin dynamics in breast cancer cells
    Olivia McGinn, Ashley V. Ward, Lynsey M. Fettig, Duncan Riley, Joshua Ivie, Kiran Vinod-Paul, Peter Kabos, Jessica Finlay-Schultz, Carol A. Sartorius · 2020 · Oncogene
  45. MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination
    Min Cong, Yuan Wang, Yang Yang, Cheng Lian, Xueqian Zhuang, Xiaoxun Li, Peiyuan Zhang, Yingjie Liu, Jun Tang, Qifeng Yang et al. · 2020 · Nature Cancer
  46. Breast cancer and cancer stem cells: a mini-review.
    Alžběta Filipová, Martina Seifrtová, Jaroslav Mokrý, Josef Dvořák, Martina Řezáčová, Stanislav Filip, Daniel Diaz Garcia · 2014 · PubMed
  47. BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer
    Edgar S. Díaz‐Cruz, Marina Carla Cabrera, Rebecca E. Nakles, Beth H. Rutstein, Priscilla A. Furth · 2011 · Breast Disease
  48. Prostate Cancer and Parasitism of the Bone Hematopoietic Stem Cell Niche
    Chunyan Yu, Yusuke Shiozawa, Russell S. Taichman, Laurie K. McCauley, Kenneth J. Pienta, Evan T. Keller · 2012 · Critical Reviews in Eukaryotic Gene Expression
  49. The Presence of EpCAM-/CD49f+Cells in Breast Cancer Is Associated with a Poor Clinical Outcome
    Feng Ye, Yan Qiu, Li Li, Libo Yang, Fei Cheng, Hongying Zhang, Bing Wei, Zhang Zhang, Linyong Sun, Hong Bu · 2015 · Journal of Breast Cancer
  50. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort
    Jeffrey E. Johnson, Michael Phillip Choi, Farnaz Dadmanesh, Bingchen Han, Ying Qu, Yi Yu-Rice, Xiao Zhang, Sanjay Prakash Bagaria, Clive R. Taylor, Armando E. Giuliano et al. · 2016 · Oncotarget
  51. A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression
    Yu Liu, Peter John, Kenta Nishitani, Jihong Cui, Christopher Nishimura, John R. Christin, Nicole Couturier, Xiaoxin Ren, Wei Yao, Marc C. Pulanco et al. · 2023 · Developmental Cell
  52. FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters
    Mengjiao Li, Tatsunori Nishimura, Yasuto Takeuchi, Tsunaki Hongu, Yuming Wang, Daisuke Shiokawa, Kang Wang, Haruka Hirose, Asako Sasahara, Masao Yano et al. · 2023 · Journal of Clinical Investigation
  53. Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy
    Adam D. Pfefferle, Benjamin T. Spike, Geoff Wahl, Charles M. Perou · 2015 · Breast Cancer Research and Treatment
  54. BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer
    Maja Sedic, Charlotte Kuperwasser · 2016 · Cell Cycle
  55. Characterization of mammary epithelial stem/progenitor cells and their changes with aging in common marmosets
    Anqi Wu, Qiaoxiang Dong, Hui Gao, Yuanshuo Shi, Yuanhong Chen, Fuchuang Zhang, Abhik M. Bandyopadhyay, Danhan Wang, Karla M. Gorena, Changjiang Huang et al. · 2016 · Scientific Reports
  56. CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer
    Feng Ye, Xiaorong Zhong, Yan Qiu, Libo Yang, Bing Wei, Zhang Zhang, Hong Bu · 2017 · Journal of Breast Cancer
  57. Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity
    Juliane Strietz, Stella S. Stepputtis, Marie Follo, Peter Bronsert, Elmar Stickeler, Jochen Maurer · 2021 · International Journal of Molecular Sciences
  58. A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations
    Song Nie, Sean McDermott, Yadwinder S. Deol, Zhijing Tan, Max S. Wicha, David M. Lubman · 2015 · PROTEOMICS
  59. ROCK1 Inhibition Promotes the Self-Renewal of a Novel Mouse Mammary Cancer Stem Cell
    David J. Castro, Jochen Maurer, Lionel Hebbard, Robert G. Oshima · 2012 · Stem Cells
  60. Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer
    Kristi Krüger, Elisabeth Wik, Gøril Knutsvik, Hawa Nalwoga, Tor Audun Klingen, Jarle B. Arnes, Ying Chen, Monica Mannelqvist, Konstantina Dimitrakopoulou, Ingunn M. Stefansson et al. · 2017 · Scientific Reports
  61. Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit
    Chanel Elisha Smart, Ania Wronski, Juliet D. French, Stacey L. Edwards, Marie-Liesse Asselin-Labat, Nicola Waddell, Kate M. Peters, Brooke L. Brewster, Kelly M. Brooks, Kaylene J. Simpson et al. · 2010 · Oncogene
  62. Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer
    Anna L. Stratford, Kristen M. Reipas, Christopher A. Maxwell, Sandra Elaine Dunn · 2010 · Expert Reviews in Molecular Medicine
  63. Breast Cancer Progression and Its Theranostic Management via Folate-Directed Targeting of Glycoprotein Receptor
    Koyeli Girigoswami, Agnishwar Girigoswami · 2025 · Medical Sciences
  64. Tumor-initiating cells are not enriched in cisplatin-surviving BRCA1;p53-deficient mammary tumor cells in vivo
    Marina Pajic, Ariena J. Kersbergen, Frank N.J. van Diepen, Anita Pfauth, Jos Jonkers, Piet Borst, Sven Rottenberg · 2010 · Cell Cycle
  65. Unravelling the epigenomic dimension of breast cancers
    Sarah Dedeurwaerder, Debora Fumagalli, François Fuks · 2011 · Current Opinion in Oncology
  66. Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1
    Gina M. Sizemore, Subhasree Balakrishnan, Anisha M. Hammer, Katie Thies, A.J. Trimboli, Julie A. Wallace, Steven T. Sizemore, Raleigh D. Kladney, Sarah A. Woelke, Lianbo Yu et al. · 2016 · Oncogene
  67. Conserved and variable: Understanding mammary stem cells across species
    Gat Rauner, Melissa M. Ledet, Gerlinde R. Van de Walle · 2017 · Cytometry Part A
  68. Phosphine/diimine ruthenium complexes with Cl−, CO, NO+, NO2−, NO3− and pyridine ligands: Pro-apoptotic activity on triple-negative breast cancer cells and DNA/HSA interactions
    Henrique Vieira Reis Silva, Júlia Scaff Moreira Dias, Guilherme Álvaro Ferreira‐Silva, Legna Colina–Vegas, Marisa Ionta, Charlane C. Corrêa, Alzir Azevedo Batista, Marília I.F. Barbosa, Antonio Carlos Doriguetto · 2018 · Polyhedron
  69. Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives
    Flávia Lima Costa Faldoni, Cláudia Aparecida Rainho, Sílvia Regina Rogatto · 2020 · Cells
  70. Lineage Plasticity in Cancer: The Tale of a Skin-Walker
    Archana P. Thankamony, Ayalur Raghu Subbalakshmi, Mohit Kumar Jolly, Radhika Nair · 2021 · Cancers
  71. Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
    Thomas E. Bartlett, Iona Evans, Allison Jones, J. James E. Barrett, Shaun S. Haran, Daniel Reisel, Kiriaki Papaikonomou, J. Louise Jones, Chiara Maria Stella Herzog, Nora Pashayan et al. · 2022 · Genome Medicine
  72. Self-Renewing Pten-/-TP53-/- Protospheres Produce Metastatic Adenocarcinoma Cell Lines with Multipotent Progenitor Activity
    Wassim G. Abou-Kheir, Paul G. Hynes, Philip Martin, Juan Juan Yin, Yen‐Nien Liu, Victoria Seng, Ross G. Lake, Joshua M. Spurrier, Kathleen Kelly · 2011 · PLoS ONE
  73. Cancer Stem Cells in the Human Mammary Gland and Regulation of Their Differentiation by Estrogen
    Bruno M. Simões, María dM Vivanco · 2011 · Future Oncology
  74. Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Eun Yoon Cho, Myung Hee Chang, Yoon‐La Choi, Jeong Eon Lee, Seok Jin Nam, Jung‐Hyun Yang, Yeon Hee Park, Jin Seok Ahn, Young‐Hyuck Im · 2010 · Cancer Chemotherapy and Pharmacology
  75. Tissue proteomics of the human mammary gland: Towards an abridged definition of the molecular phenotypes underlying epithelial normalcy
    José M.A. Moreira, Teresa Cabezón, Irina Gromova, Pavel Gromov, Vera Timmermans Wielenga, Isidro Machado, Antonio Llombart‐Bosch, Niels T. Kroman, Fritz E Rank, Julio E. Celis · 2010 · Molecular Oncology
  76. ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancer
    Laura A Baker, Holly Holliday, Alexander Swarbrick · 2016 · Endocrine Related Cancer
  77. An Integrated Human Mammary Epithelial Cell Culture System for Studying Carcinogenesis and Aging
    Martha R. Stampfer, Mark A. LaBarge, James C. Garbe · 2013 · Humana Press eBooks
  78. CD24 expression and stem-associated features define tumor cell heterogeneity and tumorigenic capacities in a model of carcinogenesis
    Paola Ortíz-Montero, Win-Yan Liu-Bordes, Arturo Londoño‐Vallejo, Jean‐Paul Vernot · 2018 · Cancer Management and Research
  79. Anatomical localization of progenitor cells in human breast tissue reveals enrichment of uncommitted cells within immature lobules
    Lisa M. Arendt, Patricia J. Keller, Adam Skibinski, Kevin Goncalves, Stephen P. Naber, Rachel J. Buchsbaum, Hannah L. Gilmore, Steven E. Come, Charlotte Kuperwasser · 2014 · Breast Cancer Research
  80. Targeting breast cancer through its microenvironment: Current status of preclinical and clinical research in finding relevant targets
    Hilde H. Nienhuis, Sietske B.M. Gaykema, Hetty Timmer‐Bosscha, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub–de Hooge, Bert van der Vegt, Beth A. Overmoyer, Elisabeth G.E. de Vries, Carolina Pia Schroder · 2014 · Pharmacology & Therapeutics
  81. Genetic traits for hematogeneous tumor cell dissemination in cancer patients
    Simon Andreas Joosse, Klaus Pantel · 2016 · Cancer and Metastasis Reviews
  82. Targeted therapy against cancer stem cells
    Tao Yang, Kiera Rycaj · 2015 · Oncology Letters
  83. A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation
    Angela Burleigh, Steven E. McKinney, Jazmine Brimhall, Damian Yap, Peter D. Eirew, Steven S.S. Poon, Viola Ng, Adrian N. C. Wan, Leah Prentice, Lois A. Annab et al. · 2015 · Breast Cancer Research
  84. Human Breast Progenitor Cell Numbers Are Regulated by WNT and TBX3
    Arendt, Lisa M., St. Laurent, Jessica, Wronski, Ania, Caballero, Silvia, Lyle, Stephen R., Naber, Stephen P., Kuperwasser, Charlotte · 2014 · PLoS ONE
  85. Cell Fate Decisions During Breast Cancer Development
    Kayla M. Gross, Ania Wronski, Adam Skibinski, Sarah M. Phillips, Charlotte Kuperwasser · 2016 · Journal of Developmental Biology
  86. Mass Cytometric Analysis Reveals Viable Activated Caspase-3+ Luminal Progenitors in the Normal Adult Human Mammary Gland
    David J. H. F. Knapp, Nagarajan Kannan, Davide Pellacani, Connie J. Eaves · 2017 · Cell Reports
  87. Cells of Origin for Prostate Cancer
    Li Xin · 2019 · Advances in experimental medicine and biology
  88. Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype
    Hui zi Li, Sara Duhachek-Muggy, Suzanne R. Dubnicka, Anna Żółkiewska · 2013 · Breast Cancer Research and Treatment
  89. Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution
    Prashant Kumar, Malini Mukherjee, Jacob P. S. Johnson, Milan Patel, Bing Huey, Donna G. Albertson, Karl J. Simin · 2012 · PLoS Genetics
  90. PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
    Christina M. Annunziata, Susan Elaine Bates · 2010 · F1000 Biology Reports
  91. Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis
    Denise K. Reaves, Katherine A. Hoadley, Katerina D. Fagan‐Solis, Dereje D. Jima, Michael S. Bereman, Lynnelle Thorpe, Jyla Hicks, David A. McDonald, Melissa A. Troester, Charles M. Perou et al. · 2016 · Molecular Cancer Research
  92. A TGFβ–miR-182–BRCA1 axis controls the mammary differentiation hierarchy
    Haydeliz Martinez‐Ruiz, Irineu Illa-Bochaca, Coral Oghenerukevwe Omene, Douglas Hanniford, Qi Liu, Eva Hernando, Mary Helen Barcellos‐Hoff · 2016 · Science Signaling
  93. Hormones induce the formation of luminal-derived basal cells in the mammary gland
    Wenqian Song, Ran Wang, Weimin Jiang, Qi Yin, Guangdun Peng, Ruikai Yang, Qing Cissy Yu, Jianfeng Chen, Jingsong Li, Tom H. Cheung et al. · 2019 · Cell Research
  94. Single-Cell RNA Sequencing of a Postmenopausal Normal Breast Tissue Identifies Multiple Cell Types That Contribute to Breast Cancer
    Sen Peng, Lora L. Hebert, Jennifer M. Eschbacher, Suwon Kim · 2020 · Cancers
  95. Getting to the Root of BRCA1-Deficient Breast Cancer
    Christophe Ginestier, Suling Liu, Max S. Wicha · 2009 · Cell stem cell
  96. Serine starvation silences estrogen receptor signaling through histone hypoacetylation
    Albert Mao Li, Bo He, Dimitris Karagiannis, Yang Li, Haowen Jiang, Preethi Srinivasan, Yaniel Ramirez, Meng-Ning Zhou, Christina N. Curtis, Joshua James Gruber et al. · 2023 · Proceedings of the National Academy of Sciences
  97. Single-cell analyses reveal evolution mimicry during the specification of breast cancer subtype
    Zhijie Gao, Huan Fang, Si Sun, Si-Qing Liu, Fang Zhou, Zhou Liu, Bei Li, Ping Wang, Shengrong Sun, Xiangyu Meng et al. · 2024 · Theranostics
  98. Single-nucleus chromatin accessibility and transcriptomic map of breast tissues of women of diverse genetic ancestry
    Poornima Bhat‐Nakshatri, Hongyu Gao, Aditi Sanjay Khatpe, Adedeji Kolawole Adebayo, Patrick C. McGuire, Cihat Erdoğan, Duojiao Chen, Guanglong Jiang, Felicia New, Rana German et al. · 2024 · Nature Medicine
  99. Establishment of a normal-derived estrogen receptor-positive cell line comparable to the prevailing human breast cancer subtype
    Branden Michael Hopkinson, Marie Christine Klitgaard, OLE WILLIAM PETERSEN, René Villadsen, Lone Rønnov‐Jessen, Jiyoung Kim · 2017 · Oncotarget
  100. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas
    A. Cakir, İpek Işık Gönül, Özgür Ekinci, Bülent Çetin, Mustafa Beneklı, Ömer Uluoğlu · 2017 · Pathology - Research and Practice